MADRID, October 18, 2023 /PRNewswire/ — SUANFARMA, through its R&D division, celebrates the historic agreement reached with Reyoung Pharmaceutical, a leader in the manufacture of active ingredients since 1966. Reyoung’s decades of experience as an exporter of products worldwide align perfectly with SUANFARMA, which has been present in the pharmaceutical and nutritional ingredients market for 30 years.
This bilateral agreement between the Spanish multinational, which provides the technology developed internally, and its partner Reyoung, with recognized reliability in manufacturing capabilities, will constitute a strategic cooperation for the production of active pharmaceutical ingredients in the field of anti-infectives and antibacterials. These medicines are essential to guarantee the health of the population. Both companies consider it essential to ensure the supply of this therapeutic line, especially in these times of shortage and growing uncertainty in the supply chain for the pharmaceutical industry worldwide.
SUANFARMA is committed to health and innovation, which is why it develops and produces accessible raw materials that meet the highest regulatory requirements of the EMA or the FDA. Additionally, the company is also dedicated to environmentally responsible practices, adopting green chemistry and prioritizing environmental protection. To this end, its strong R&D team works on developing technologies to achieve maximum efficiency in its processes and to incorporate cutting-edge active ingredients into its portfolio.
The innovative technology developed by SUANFARMA involves Flow Chemistry, improving yields, selection and reproducibility of the processes. Minimizes reaction times and requires smaller quantities of reagents and solvents, reducing raw material use and environmental impact. Additionally, this technique is generally safer than traditional synthesis, reducing the risk of explosions and spills of dangerous reagents.
“We are excited to join forces with SUANFARMA in this transformative collaboration, which combines innovation with exceptional product delivery. This alliance marks the beginning of an exciting journey, and we are confident that our collaboration will bring immense value to our customers and partners. by leveraging the unique strengths and capabilities of each organization,” said Mr. Xie, Vice President of Reyoung Pharmaceutical.
“This important strategic agreement between Reyoung and SUANFARMA highlights our shared commitment to technology-driven innovation and maximizing efficiency to deliver superior products to patients. Reyoung’s exceptional collaboration as our ally reinforces our global position, marking the first milestone in what we anticipate will be an extremely promising collaboration between our organizations,” says Javier Calvo, Director of R&D.
This significant agreement is expected to be the beginning of a strong collaboration with very promising results for the benefit of patients.
We are fully committed to improving the health of both humans and animals, striving to prevent diseases in a sustainable way.
About SUANFARMA
SUANFARMA, founded in 1993, is a B2B life sciences company specialized in the development, production and marketing of ingredients for the pharmaceutical, veterinary and nutraceutical industries.
Sobre Reyoung
Reyoung is a modern, vertically integrated pharmaceutical company that focuses on improving the quality of its products through innovation as the basis of its process.
Photo – https://mma.prnewswire.com/media/2248559…Logo – https://mma.prnewswire.com/media/2234752…
View original content: https://www.prnewswire.com/news-releases/suanfarma-anuncia-una-colaboracion-con-reyoung-pharmaceutical-para-ampliar-la-cartera-existente-de-productos-antiinfecciosos-y-antibacterianos-301957915.html
